Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$59.8K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 8 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 10 most recent Form 4 transactions.
| May 13 | KPTI | Karyopharm Therapeutics… | AGRANT | 896 | — | — | +0.9% | Open the original filing on SEC.gov |
| Mar 2 | KPTI | Karyopharm Therapeutics… | SSELL | 5,101 | $9.41 | $48K | -5.1% | Open the original filing on SEC.gov |
| Feb 17 | KPTI | Karyopharm Therapeutics… | SSELL | 378 | $8.63 | $3.3K | -0.4% | Open the original filing on SEC.gov |
| Jan 31 | KPTI | Karyopharm Therapeutics… | AGRANT | 32,415 | — | — | +48.1% | Open the original filing on SEC.gov |
| Oct 15, 2025 | KPTI | Karyopharm Therapeutics… | AGRANT | 39,682 | — | — | +143.2% | Open the original filing on SEC.gov |
| Sep 15, 2025 | KPTI | Karyopharm Therapeutics… | SSELL | 401 | $6.43 | $2.6K | -1.4% | Open the original filing on SEC.gov |
| Sep 12, 2025 | KPTI | Karyopharm Therapeutics… | AGRANT | 888 | — | — | +3.3% | Open the original filing on SEC.gov |
| Jul 29, 2025 | KPTI | Karyopharm Therapeutics… | SSELL | 191 | $4.37 | $835 | -0.7% | Open the original filing on SEC.gov |